Drug Profile
Somatropin - rEVO Biologics
Alternative Names: Human growth hormone - GTCLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator GTC Biotherapeutics
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Somatotropin deficiency
Most Recent Events
- 04 Jan 2013 GTC Biotherapeutics is now called rEVO Biologics
- 15 Oct 2002 Discontinued - Preclinical for Somatotropin deficiency in USA (unspecified route)
- 18 Jun 2002 Genzyme Transgenics Corporation is now called GTC Biotherapeutics